Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery

Recruiting N/A Interventional Study
Breast Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
4,052 (estimated)
Sponsor
Fudan University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The study was designed to investigate whether hypofractionated radiotherapy(HF-RT) is noninferior to conventionally fractionated radiotherapy (CF-RT) in terms of tumor loco-regional control for patients after breast conserving surgery

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Female * Age18-70 years * Imaging examination confirmed single lesion. if the tumor is multiple, it needs to be removed by single quadrantectomy * Receive breast conserving surgery with negative margins * Axillary lymph nodes treatment: Sentinel lymph node biopsy or level I/II…
Contacts

Xiaoli Yu, MD, PhD

+86-13817893133

stephanieyxl@hotmail.com

CONTACT

Jurui Luo, PhD

+86-13162996951

juruiluo@hotmail.com

CONTACT